Giuseppina Rea

539 total citations
18 papers, 340 citations indexed

About

Giuseppina Rea is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Giuseppina Rea has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Giuseppina Rea's work include Cancer Immunotherapy and Biomarkers (10 papers), Chemokine receptors and signaling (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Giuseppina Rea is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Chemokine receptors and signaling (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Giuseppina Rea collaborates with scholars based in Italy, United States and Malaysia. Giuseppina Rea's co-authors include Stefania Scala, Gerardo Botti, Crescenzo D’Alterio, Maria Napolitano, Caterina Ieranò, Luigi Portella, Massimiliano Berretta, Vincenzo Quagliariello, Nicola Maurea and Fabiana Tatangelo and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Giuseppina Rea

18 papers receiving 338 citations

Peers

Giuseppina Rea
Olga Goncharova Kyrgyzstan
Costakis Frangou United States
Yani Peng China
Jieli Han China
Debayan Mukherjee United Kingdom
Peiman Liu United States
Giuseppina Rea
Citations per year, relative to Giuseppina Rea Giuseppina Rea (= 1×) peers Salvatore Volpe

Countries citing papers authored by Giuseppina Rea

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Rea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Rea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Rea more than expected).

Fields of papers citing papers by Giuseppina Rea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Rea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Rea. The network helps show where Giuseppina Rea may publish in the future.

Co-authorship network of co-authors of Giuseppina Rea

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Rea. A scholar is included among the top collaborators of Giuseppina Rea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Rea. Giuseppina Rea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Santagata, Sara, Giuseppina Rea, Maria Napolitano, et al.. (2023). Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment. Hepatology International. 18(2). 568–581. 10 indexed citations
2.
Moriello, Aniello Schiano, Fiorentina Roviezzo, Fabio Arturo Iannotti, et al.. (2022). First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury. Biomolecules. 13(1). 33–33. 5 indexed citations
4.
Tomassi, Stefano, Caterina Ieranò, Alessandra Del Bene, et al.. (2022). Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides. International Journal of Molecular Sciences. 23(15). 8504–8504. 2 indexed citations
5.
Riemma, Maria Antonietta, Ida Cerqua, Barbara Romano, et al.. (2021). Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease. British Journal of Pharmacology. 179(8). 1753–1768. 27 indexed citations
6.
Ottaiano, Alessandro, Stefania Scala, Crescenzo D’Alterio, et al.. (2021). Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Therapeutic Advances in Medical Oncology. 13. 4277423487–4277423487. 24 indexed citations
7.
Quagliariello, Vincenzo, Michelino De Laurentiis, Stefania Cocco, et al.. (2020). NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 21(20). 7802–7802. 67 indexed citations
8.
Arx, Claudia von, Giuseppina Rea, Maria Napolitano, et al.. (2020). Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study. Cancers. 12(9). 2422–2422. 9 indexed citations
9.
Tomassi, Stefano, Anna Maria Trotta, Caterina Ieranò, et al.. (2020). Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. Chemistry - A European Journal. 26(44). 10113–10125. 14 indexed citations
10.
Santagata, Sara, Anna Maria Trotta, Giuseppina Rea, et al.. (2020). Abstract 6675: Basal NK activity and early Tregs inhibition predicts nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial. Cancer Research. 80(16_Supplement). 6675–6675. 1 indexed citations
11.
D’Alterio, Crescenzo, Antonella Zannetti, Anna Maria Trotta, et al.. (2020). New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer. Cancers. 12(7). 1952–1952. 17 indexed citations
12.
Ieranò, Caterina, Crescenzo D’Alterio, Maria Napolitano, et al.. (2019). CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells. Cell Death and Disease. 10(8). 562–562. 17 indexed citations
13.
Camerlingo, Rosa, Laura Marra, Giuseppina Rea, et al.. (2019). Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation. PLoS ONE. 14(7). e0219597–e0219597. 30 indexed citations
14.
D’Alterio, Crescenzo, Maria Buoncervello, Caterina Ieranò, et al.. (2019). Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1. Journal of Experimental & Clinical Cancer Research. 38(1). 432–432. 81 indexed citations
15.
Santagata, Sara, Anna Maria Trotta, Giuseppina Rea, et al.. (2019). Basal NK activity and early Treg function inhibition predicts Nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial. Annals of Oncology. 30. v772–v772. 1 indexed citations
16.
Ieranò, Caterina, Crescenzo D’Alterio, Maria Napolitano, et al.. (2019). Abstract 4103: Blockade of intrinsic PD-1 promotes human colon cancer cells survival, chemo resistance and in vivo tumor growth of human colon cancer cells. Cancer Research. 79(13_Supplement). 4103–4103. 1 indexed citations
17.
Trotta, Anna Maria, Sara Santagata, Serena Zanotta, et al.. (2018). Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity. Journal of Experimental & Clinical Cancer Research. 37(1). 297–297. 18 indexed citations
18.
Tomassi, Stefano, Caterina Ieranò, Ersilia Nigro, et al.. (2018). Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers. Bioorganic & Medicinal Chemistry. 26(9). 2539–2550. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026